Wellington Management Group
AZN icon

Wellington Management Group’s AstraZeneca AZN Stock Holding History

Wellington Management Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-632
Closed -$702K – 2199
2017
Q4 		$702K Buy
632
+194
+44% +$13.1K ﹤0.01% 1983
2017
Q3 		$473K Buy
+438
New +$27.7K ﹤0.01% 2051

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM

Wellington Management Group's AZN Position: Q2 2026 in Review

Wellington Management Group increased its AstraZeneca (AZN) stake by 20% in Q2 2026, buying an estimated $900M and bringing the position to 28,537,243 shares worth $5.36B. The position accounts for 0.92% of the portfolio, ranked #14.

Wellington Management Group first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. 1,503 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Wellington Management Group held 28,537,243 shares of AstraZeneca worth $5.36B as of Q2 2026.
  • Wellington Management Group bought 4,786,158 AstraZeneca shares in Q2 2026, an estimated $900M.
  • AstraZeneca made up 0.92% of Wellington Management Group's portfolio in Q2 2026, its #14 holding.
  • Wellington Management Group first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
  • 1,503 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.